These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 7994822)

  • 21. Effects of angiotensin-converting enzyme inhibition with perindopril on hemodynamics, arterial structure, and wall rheology in the hindquarters of atherosclerotic mini-pigs.
    Rolland PH; Charpiot P; Friggi A; Piquet P; Barlatier A; Scalbert E; Bodard H; Tranier P; Mercier C; Luccioni R
    Am J Cardiol; 1993 Jun; 71(17):22E-27E. PubMed ID: 8328363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A selective angiotensin receptor antagonist, Valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness.
    Suzuki H; Nakamoto H; Okada H; Sugahara S; Kanno Y
    Adv Perit Dial; 2003; 19():59-66. PubMed ID: 14763035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin converting enzyme inhibition, pulse wave velocity and ambulatory blood pressure measurements in essential hypertension.
    Santoni JP; Asmar R; Safar ME
    Clin Exp Hypertens A; 1989; 11 Suppl 2():535-44. PubMed ID: 2691127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perindopril: an updated review of its use in hypertension.
    Hurst M; Jarvis B
    Drugs; 2001; 61(6):867-96. PubMed ID: 11398915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effects of angiotensin-converting enzyme inhibition on the arterial wall of adult spontaneously hypertensive rats.
    Levy BI; Michel JB; Salzmann JL; Poitevin P; Devissaguet M; Scalbert E; Safar ME
    Am J Cardiol; 1993 Jun; 71(17):8E-16E. PubMed ID: 8328370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regression of left ventricular hypertrophy--a meta-analysis.
    Dahlöf B; Pennert K; Hansson L
    Clin Exp Hypertens A; 1992; 14(1-2):173-80. PubMed ID: 1347256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term effects of rilmenidine on left ventricular hypertrophy and systolic and diastolic function in patients with essential hypertension: comparison with an angiotensin converting enzyme inhibitor and a calcium antagonist.
    Koldas L; Ayan F; Ikitimur B
    Jpn Heart J; 2003 Sep; 44(5):693-704. PubMed ID: 14587651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normalization of structural cardiovascular changes during antihypertensive treatment with a regimen based on the ACE-inhibitor perindopril.
    Sihm I; Schroeder AP; Aalkjaer C; Holm M; Mørn B; Mulvany M; Thygesen K; Lederballe O
    Blood Press; 1995 Jul; 4(4):241-8. PubMed ID: 7496564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind trial of perindopril and nitrendipine in incipient diabetic nephropathy.
    Kopf D; Schmitz H; Beyer J; Frank M; Bockisch A; Lehnert H
    Diabetes Nutr Metab; 2001 Oct; 14(5):245-52. PubMed ID: 11806464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension.
    Asmar RG; Journo HJ; Lacolley PJ; Santoni JP; Billaud E; Levy BI; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S33-9. PubMed ID: 3225688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACE inhibition with perindopril and atherogenesis-induced structural and functional changes in minipig arteries.
    Charpiot P; Rolland PH; Friggi A; Piquet P; Scalbert E; Bodard H; Barlatier A; Latrille V; Tranier P; Mercier C
    Arterioscler Thromb; 1993 Aug; 13(8):1125-38. PubMed ID: 8343488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study.
    de Luca N; Mallion JM; O'Rourke MF; O'Brien E; Rahn KH; Trimarco B; Romero R; De Leeuw PW; Hitzenberger G; Battegay E; Duprez D; Sever P; Safar ME
    Am J Hypertens; 2004 Aug; 17(8):660-7. PubMed ID: 15323062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.
    Weinberg EO; Schoen FJ; George D; Kagaya Y; Douglas PS; Litwin SE; Schunkert H; Benedict CR; Lorell BH
    Circulation; 1994 Sep; 90(3):1410-22. PubMed ID: 8087951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the efficacy and tolerability of nitrendipine in reducing both pressure and left ventricular mass in hypertensive type 2 diabetic patients.
    Scognamiglio R; Nosadini R; Marin M; Nisti S; Fasoli G; Palisi M; Frigato F; Virgili F; Carraro A; Crepaldi G
    Diabetes Care; 1997 Aug; 20(8):1290-2. PubMed ID: 9250456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects.
    de Luca N; Asmar RG; London GM; O'Rourke MF; Safar ME;
    J Hypertens; 2004 Aug; 22(8):1623-30. PubMed ID: 15257187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regression of cardiovascular structural changes after long-term antihypertensive treatment with the calcium antagonist nitrendipine.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Romanelli G; Beschi M; Castellano M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S5-9. PubMed ID: 1725798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood pressure independent effects of nitrendipine on cardiac structure in patients after renal transplantation.
    Rockstroh JK; Schobel HP; Vogt-Ladner G; Hauser I; Neumayer HH; Schmieder RE
    Nephrol Dial Transplant; 1997 Jul; 12(7):1441-7. PubMed ID: 9249783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
    Almazov VA; Shlyakhto EV; Konrady AO; Macsimova TA; Zaharov DV; Rudomanov OG
    Med Sci Monit; 2000; 6(2):309-13. PubMed ID: 11208328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The angiotensin-converting enzyme inhibitor, perindopril, prevents cardiac hypertrophy in low-renin hypertensive rats.
    Nakamura F; Nagano M; Higaki J; Higashimori K; Morishita R; Mikami H; Ogihara T
    Clin Exp Pharmacol Physiol; 1993 Mar; 20(3):135-40. PubMed ID: 8467569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.